tiprankstipranks
Trending News
More News >
Austar Lifesciences Ltd. (HK:6118)
:6118
Hong Kong Market
Advertisement

Austar Lifesciences Ltd. (6118) Income Statement

Compare
0 Followers

Austar Lifesciences Ltd. Income Statement

Last quarter (Q4 2024), Austar Lifesciences Ltd.'s total revenue was ¥799.48M, a decrease of -27.58% from the same quarter last year. In Q4, Austar Lifesciences Ltd.'s net income was ¥10.20M. See Austar Lifesciences Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.50B¥ 1.76B¥ 2.23B¥ 2.02B¥ 1.30B
Gross Profit
¥ 301.22M¥ 336.05M¥ 462.67M¥ 479.01M¥ 323.53M
Operating Expenses
¥ 266.04M¥ 366.04M¥ 368.21M¥ 156.85M¥ 282.36M
Depreciation and Amortization
¥ 35.94M¥ 45.60M¥ 37.01M¥ 31.57M¥ 31.90M
EBITDA
¥ 70.71M¥ 25.15M¥ 166.13M¥ 130.62M¥ 39.83M
Operating Income
¥ 35.18M¥ -29.99M¥ 90.39M¥ 116.97M¥ 26.38M
Other Income/Expenses
¥ -14.01M¥ -4.42M¥ -29.89M¥ 202.26M¥ 15.11M
Pretax Income
¥ 21.17M¥ -34.41M¥ 86.48M¥ 319.23M¥ 41.49M
Net Income
¥ 16.08M¥ -113.47M¥ 87.46M¥ 277.30M¥ 33.10M
Per Share Metrics
Basic EPS
¥ 0.03¥ -0.22¥ 0.17¥ 0.54¥ 0.06
Diluted EPS
¥ 0.03¥ -0.22¥ 0.17¥ 0.54¥ 0.06
Weighted Average Shares Outstanding
512.59M 514.50M 512.58M 512.58M 512.58M
Weighted Average Shares Outstanding (Diluted)
512.58M 512.58M 512.58M 512.58M 512.58M
Currency in CNY

Austar Lifesciences Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis